Hydroxycitric acid inhibits oxalate nephropathies formation through crystallization regulation and activation of the PPARα pathway
Y.-H. Zhang, S.-J. Li, B.-X. Yu, Q. Liang, X.-Y. Sun
This study shows hydroxycitric acid inhibits oxalate nephropathies by reducing calcium oxalate crystal deposition and activating the PPARα pathway.
bioRxiv · Dec 5, 2022 · PreprintBiochemistry